1 / 12

Huntington’s Disease

Huntington’s Disease. Physiopathology and Phenotype. Borbála Szepes Kevin Pommier. Nantes, 15 th of September 2014. What is HD ?. n eurodegenerative genetic disorder of the CNS a lso known as Huntington chorea a utosomic d ominant mutation t rinucleotid e repeat disorders (CAG)

tobias-hatfield
Télécharger la présentation

Huntington’s Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Huntington’sDisease Physiopathology and Phenotype BorbálaSzepes Kevin Pommier Nantes, 15th of September 2014

  2. What is HD ? • neurodegenerative genetic disorder of the CNS • also known as Huntington chorea • autosomic dominant mutation • trinucleotide repeat disorders (CAG) • dynamic mutation • anticipation phenomenon • complete penetrance • prevalence : 1/10 000

  3. Huntingtin protein • product of Huntington gene (chromosome4p16.3) • soluble protein of 3144 AA • ubiquitously present but highest concentration in CNS neurons • associated with various organelles • also found in neurites and synapses (associated with vesicular structures) • role of thepolyQregion +++:polymorphism of the gene can lead to variablenumbers of glutamine residues present in the protein • normal protein: 6-35 glutamine residues • abnormal: over 36 • Main functions : • embryonicdevelopment regulator • antiapoptotic • control BDNF production(↑ transcription) • axonal and vesicular transportHuntingtin and BDNF vesicle transport • synaptic activity

  4. Physiopathology

  5. Why is HD limited to neurons and particularly to striatal neurons? • highly debated phenomen, only theories! • neural presence: associated proteins • HIP-1: huntingtin's interactor protein • HAP-1: huntingtin's associated protein • important sign: chorea → malfunction of the striatum • anatomical background : basal ganglia • striatum : caudate nucleus + putamen inhibitory pathway • Htt promotes axonal BDNF transport from the cerebral cortex to the striatum • essential!, not produced by striatal neurons • mutant Htt → deficiency in BDNF-mediated signaling → striatal atrophy (90%!) → chorea • progressively affects other structures and pathways

  6. Classification • Adult HD (mean age of onset ~ 35-44 yrs) • 95 % of all cases • 3 stages • Juvenile HD (mean age of onset ~ infancy-20 yrs) • same genetical alteration different phenotype • differences: • stiffness, rigidity, seizures • no chorea! • more rapid progression • similarities: • dementia • psychological changes • neurogical damage

  7. “pre-clinical”

  8. References • http://omim.org/entry/143100?search=huntington%20disease&highlight=huntington%20disease • http://www.ncbi.nlm.nih.gov/books/NBK1305/ • http://www.dailymotion.com/video/xbx3e5_patrick-pla-la-maladie-de-huntingto_tech • https://web.stanford.edu/group/hopes/cgi-bin/wordpress/?p=3419 • http://www.intechopen.com/books/huntington-s-disease-core-concepts-and-current-advances/bdnf-in-huntington-s-disease-role-in-pathogenesis-and-treatment • https://www.youtube.com/watch?v=my-ONvDYqpI

  9. Any questions? Thank you for your attention!

More Related